tiprankstipranks
Trending News
More News >
Genmab A/S (GB:0MGB)
LSE:0MGB

Compare Genmab A/S (0MGB) vs. Competitors

Compare
13 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Genmab A/S
kr2180.48
kr134.57B
13.65
43.58%
4 Buy
2 Hold
0 Sell
Moderate Buy
GlaxoSmithKline
1816.50p
£73.28B
13.43
34.71%
3 Buy
8 Hold
4 Sell
Hold
AstraZeneca
14052.00p
£217.87B
30.26
29.58%
12 Buy
2 Hold
1 Sell
Moderate Buy
Hikma Pharmaceuticals
1570.00p
£3.46B
12.12
-24.23%
5 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0MGB
Genmab A/S
2,180.48
677.68
45.09%
GB:GSK
GlaxoSmithKline
1,816.50
519.56
40.06%
GB:AZN
AstraZeneca
14,052.00
3,486.76
33.00%
GB:HIK
Hikma Pharmaceuticals
1,570.00
-446.91
-22.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts